Mergers & Acquisitions

Agilent to sell Resolution Bioscience to Exact Sciences

Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.

September 12, 2023

LabGenomics USA acquires QDx Pathology

In a strategic move to expand its North American market, LabGenomics USA, a subsidiary of South Korea-based LabGenomics, has acquired diagnostic and molecular service provider QDx Pathology.

September 6, 2023

Danaher to acquire Abcam for $5.7B

Science and medical technology firm Danaher announced Monday that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays.

August 29, 2023

Agilent closes $550M liquid biopsy unit after failing to find path to profits

When Agilent bought Resolution, it identified the company’s presence in fast-growing NGS technologies for precision oncology as a way to expand its addressable market; rather than realizing that opportunity, Agilent has ended up cutting its losses.

August 18, 2023

New Day Diagnostics inks $12M deal to buy Epigenomics’ cancer technology

Epigenomics has agreed to sell “substantially all” of its assets to New Day Diagnostics, a developer of tests for the early detection and monitoring of disease that merged with EDP Biotech earlier this month.

July 31, 2023

Vector Laboratories buys Quanta Bio for polyethylene glycol technology

Single molecular weight, discrete-length PEG chains such as Quanta’s dPEG products can simplify peptide analysis compared to other products that contain a range of PEG chain lengths and molecular weights.

July 24, 2023

Applied DNA buys Spindle Biotech to improve mRNA production offering

New York-based Applied DNA will integrate its LinearDNA platform and Spindle’s RNAP to make LineaIVT, a platform that it claims will address challenges facing manufacturers of mRNA vaccines and therapies.

July 20, 2023

Novacyt to purchase Yourgene for $21.2M

In a statement, the Camberley, U.K.-based Novacyt said that the acquisition of Yourgene will diversify and expand its testing offerings and geographic footprint, a strategy in part prompted by falling demand for Novacyt’s COVID-19 testing services.

July 11, 2023

FTC mulls changes to company merger rules

The proposed rule change would amend the Hart-Scott-Rodino (HSR) form and instructions, the first time in 45 years that the agencies will perform a top-to-bottom review of the form.

June 29, 2023

Intus Bio buys Pattern Genomics to enhance microbiome analysis capabilities

Intus Bio sees the integration enhancing the platform with machine-learning tools for biomarker discovery and patient stratification, supporting the firm’s work in turning microbiome technologies into practical medical and pharmaceutical applications.

June 29, 2023

Genomics AI firm Genomenon acquires Boston Genetics

An expanded genomic interpretation team enabled by the acquisition supports its offerings for clinical diagnostic and pharmaceutical drug development programs, Genomenon said.

June 27, 2023

Bio-Techne to acquire Swiss spatial biology firm Lunaphore

Bio-Techne said that it expects to close the deal by the end of September, in the first quarter of its fiscal 2024.

June 22, 2023

Page 1 of 9

Next Page